Silver Point Capital

Silver Point Capital is a global alternative investment firm that specializes in credit and special situations. Established in 2002 by former Goldman Sachs partners Edward Mulé and Robert O'Shea, the firm manages a diverse range of strategies including direct lending, distressed debt, and structured credit. Although it is a financial services entity rather than a biotechnology developer, Silver Point is a prominent investor and lender within the healthcare and life sciences sectors. The firm provides critical capital solutions, restructuring expertise, and strategic financing to pharmaceutical companies and healthcare providers facing complex financial needs. Headquartered in Greenwich, Connecticut, Silver Point operates with a global mandate to identify value in mispriced or stressed credit assets.